CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomised, Double-blind, 3-way Crossover Study to Compare Pharmacokinetics and Safety of 10 μg BI 1744 CL Plus 5 μg Tiotropium Bromide Given as Fixed Dose Combination Via the Respimat® Inhaler With the Pharmacokinetics and the Safety of the Single Agents, i.e. 10 μg BI 1744 CL and 5 μg Tiotropium Bromide, Delivered Via the Respimat® Inhaler Following 21 Day-treatment Periods in Patients With Chronic Obstructive Pulmonary Disease (COPD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02231177
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:02.089239+00:00
Published At: 2016-01-07T00:00:00+00:00
Record Updated At: 2016-01-07
Results Posted At: 2016-01-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pulmonary Disease, Chronic Obstructive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-01-07"
protocolSection.identificationModule.nctId: "NCT02231177"
protocolSection.identificationModule.officialTitle: "A Randomised, Double-blind, 3-way Crossover Study to Compare Pharmacokinetics and Safety of 10 \u03bcg BI 1744 CL Plus 5 \u03bcg Tiotropium Bromide Given as Fixed Dose Combination Via the Respimat\u00ae Inhaler With the Pharmacokinetics and the Safety of the Single Agents, i.e. 10 \u03bcg BI 1744 CL and 5 \u03bcg Tiotropium Bromide, Delivered Via the Respimat\u00ae Inhaler Following 21 Day-treatment Periods in Patients With Chronic Obstructive Pulmonary Disease (COPD)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-01-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.